Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Amortization of Deferred Charges: 2019-2021

  • Biodesix's Amortization of Deferred Charges rose 13.89% to $41,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $147,000, marking a year-over-year change of. This contributed to the annual value of $144,000 for FY2020, which is negligibly% changed negligibly from last year.
  • Per Biodesix's latest filing, its Amortization of Deferred Charges stood at $41,000 for Q1 2021, which was up 17.14% from $35,000 recorded in Q4 2020.
  • In the past 5 years, Biodesix's Amortization of Deferred Charges registered a high of $41,000 during Q1 2021, and its lowest value of $35,000 during Q4 2019.
  • For the 3-year period, Biodesix's Amortization of Deferred Charges averaged around $36,750, with its median value being $35,500 (2019).
  • Data for Biodesix's Amortization of Deferred Charges shows a peak YoY rose of 13.89% (in 2021) over the last 5 years.
  • Quarterly analysis of 3 years shows Biodesix's Amortization of Deferred Charges stood at $35,000 in 2019, then remained steady at $35,000 in 2020, then climbed by 13.89% to $41,000 in 2021.
  • Its last three reported values are $41,000 in Q1 2021, $35,000 for Q4 2020, and $36,000 during Q1 2020.